ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

LTR Pharma (ASX:LTP) has joined forces with Strategic Drug Solutions to developed a nasal spray to treat oesophageal motility disorders.

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...

Discover AQST's growth potential with Anaphylm's FDA approval by Q2'25 targeting $1B revenue. Learn DCF valuations offering ...

Fentanyl-related overdoses are killing Texans. Dan Patrick and the state Senate should legalize fentanyl test strips to help ...

Are you a fan of this popular spice? A doctor explains why sprinkling cinnamon in your coffee is probably OK, but taking ...

The US Food and Drug Administration (FDA) has approved Atzumi, a 5.2 mg dihydroergotamine (DHE) nasal powder, for the acute ...

Momcozy launches the SniffEase Baby Nasal Aspirator with hospital-grade suction for safe, effective relief. This easy-to-use device not only provides instant congestion relief but also reduces the ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

Kindeva, a global contact development and manufacturing organization, was joined by Lieutenant Governor Jacqueline Coleman ...